Search Orphan Drug Designations and Approvals
-
| Generic Name: | Ursodiol | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Name: | URSO 250 | ||||||||||||||||
| Date Designated: | 06/20/1991 | ||||||||||||||||
| Orphan Designation: | Treatment of patients with primary biliary cirrhosis | ||||||||||||||||
| Orphan Designation Status: | Designated/Approved | ||||||||||||||||
| Sponsor: |
Aptalis Pharma US, Inc. 100 Somerset corporate Blvd Bridgewater, New Jersey 08807 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
| 1 | Generic Name: | Ursodiol |
|---|---|---|
| Trade Name: | URSO 250 | |
| Marketing Approval Date: | 12/10/1997 | |
| Approved Labeled Indication: | ||
| Exclusivity End Date: | 12/10/2004 | |
| Exclusivity Protected Indication* : | ||
-
